Merck & Company (NYSE:MRK) witnessed a selling pressure and the shares last traded with a loss of -1.6 points or -2.78% at $55.9. Investors jumped in to buy the shares on weakness. The net money flow till latest update was calculated at $122.32 million with an inflow of $204.18 million in upticks and an outflow of $81.85 million in downticks. Using the data, the up/down ratio is found to be 2.49. The share price has recorded -1.6% on a weekly basis.A block trade of $130.97 million in uptick and $6.57 million in downtick was also observed, resulting in an up/down ratio of 19.94. The net money flow of the block trade stood at a $124.4, signaling heavy buying.
Merck & Co. Inc. has dropped 0.82% in the last five trading days, however, the shares have posted positive gains of 3.07% in the last 4 weeks. Merck & Co. Inc. is up 7.84% in the last 3-month period. Year-to-Date the stock performance stands at 7.61%.
Currently the company Insiders own 0.05% of Merck & Company shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -6.72% . Institutional Investors own 74.23% of Merck & Company shares. During last six month period, the net percent change held by insiders has seen a change of -6.72%. . On the companys insider trading activities, The Securities and Exchange Commission has divulged that Golestani Clark, officer (EVP & Chief Info Officer) of Merck & Co., Inc., had unloaded 39,877 shares at an average price of $54.67 in a transaction dated on May 19, 2016. The total value of the transaction was worth $2,180,076.
Merck & Company (NYSE:MRK) witnessed a decline in the market cap on Friday as its shares dropped 2.8% or 1.61 points. After the session commenced at $57.43, the stock reached the higher end at $57.43 while it hit a low of $55.7. With the volume soaring to 17,484,401 shares, the last trade was called at $55.89. The company has a 52-week high of $60.07. The company has a market cap of $154,705 million and there are 2,768,025,300 shares in outstanding. The 52-week low of the share price is $45.69.
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products, which it markets directly and through its joint ventures. The Companys Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines. The Companys animal health products are sold to veterinarians, distributors and animal producers.